Sarah Marktel, MD^*, Robert Chiesa, MD^*, Barbara Cappelli, MD^*, Tito Roccia, MD^*, Ilaria Frugnoli, MD^*, Anna Noè, MD^*, Erika Biral, MD^*, Roberto Crocchiolo, MD^*, Costanza Evangelio, MD^*, Marco Fossati, MD^*, Sara Napolitano, MD^*, Clara Soliman^*, Laura Cursi, MD^*, Federica Cattaneo, MD^*, Laura Zito, PD^*, Rossana Fiori, MD^*, Katharina Fleischhauer, MD^*, Roberto Miniero, MD, Prof.^*, Fabio Ciceri, MD^* and Maria Grazia Roncarolo, MD, Prof.^*

Pediatric Immunohematology and Bone Marrow Transplantation Unit, Scientific Institute H S Raffaele, Milano, Italy

Corey Cutler, MD, MPH¹, J. Aldridge^2*, H. T. Kim^2*, S. Ayanian^3*, G. Bradwin^3*, C. Revta^1*, G. Murga^1*, V. Ho^1*, E. Alyea^1*, J. Koreth^1*, P. Armand^1*, P. G. Richardson^1*, R. J. Soiffer^1*, J. Ritz^1* and J. H. Antin^1*

¹Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
²Computational Biology and Biostatistics, Dana-Farber Cancer Inst., Boston, MA
³Laboratory Medicine, Children's Hospital Boston, Boston, MA

Zejing Wang, MD, PhD^1*, Mohamed L. Sorror, MD, MS^2*, Wendy Leisenring, Sc.D.^2*, Gary Schoch^1*, David G. Malonely, MD, PhD^2*, Brenda M. Sandmaier, MD² and Rainer F. Storb, MD²

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²Fred Hutchinson Cancer Research Center/ University of Washington, Seattle, WA

Hien Duong^*, Lisa Rybicki^*, John Sweetenham^*, Brad Pohlman, Ronald Sobecks, Robert Dean, Edward Copelan, Steven Andresen^*, Stephen Smith, Shawnda Sungren^*, Josephine Chan^* and Brian Bolwell

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Hirohisa Nakamae, MD, PhD^1*, D. Scott Wilbur, PhD^2*, Donald K Hamlin^2*, Monica S Thakar, MD³, Erlinda B Santos^1*, Darrell R Fisher, PhD^4*, Aimee L Kenoyer^1*, John M. Pagel, MD, PhD³, Oliver W. Press, MD, PhD³, Rainer F. Storb, MD³ and Brenda M. Sandmaier, MD³

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Radiation Oncology, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA
⁴Pacific Northwest National Laboratory, Richland, WA

Joseph Rosenthal, Jeffrey Y. Wong^*, George Somlo^*, David Snyder^*, Margaret O'Donnell^*, Anthony Stein^*, Ayurporn Nademanee^*, Maria Delioukina^*, Leslie Popplewell^*, Pablo Parker^*, Ricardo Spielberger^*, Firoozeh Sahebi^*, Chatchada Karanes^*, Debbie Hitt^*, Hossameldin Naeem^*, Andrew Dagis^* and Stephen Forman^*

City of Hope, Duarte, CA

Boglarka Gyurkocza, MD¹, Thai M. Cao, MD², Rainer F. Storb, MD¹, Thoralf Lange, MD^3*, Wendy Leisenring, Sc.D.^1*, Georg Franke, MD^3*, Mohamed L. Sorror, MD, MS^1*, David G. Maloney, MD, PhD¹, Judith Shizuru, MD, PhD^4* and Brenda M. Sandmaier, MD^1*

¹Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA
²University of Utah, Salt Lake City, UT
³University of Leipzig, Leipzig, Germany
⁴Stanford University Medical Center, Palo Alto, CA

Naoyuki Uchida, MD¹, Hisashi Yamamoto, MD^1*, Naofumi Matsuno, MD^1*, Kazuya Ishiwata, MD^1*, Masanori Tsuji, MD^1*, Shinsuke Takagi, MD^1*, Hideki Araoka, MD^2*, Daisuke Kato, MD^1*, Mayumi Yoshimi, MD^1*, Sachiko Seo, MD^1*, Kazuhiro Masuoka, MD^1*, Atsushi Wake, MD^1*, Madoka Narita^1*, Kimiko Sagawa^1*, Akiko Yoneyama, MD^2*, Shigeyoshi Makino, MD^3* and Shuichi Taniguchi, MD, PhD¹

¹Department of Hematology, Toranomon Hospital, Tokyo, Japan
²Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan
³Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan

Tapani Ruutu¹, Liisa Volin^1*, Dietrich W. Beelen^2*, Rudolf Trenschel^2*, Juergen Finke³, Marc Schnitzler^3*, Jerzy Holowiecki⁴, Sebastian Giebel^4*, Lutz Uharek^5*, I. Wolfgang Blau^5*, Matthias Stelljes^6*, Joachim Kienast^6*, Kajsa Larsson^7*, Axel R. Zander⁸, Martin Gramatzki⁹, Roland Repp^9*, Hermann Einsele^10*, Gernot Stuhler^10*, Mathias Freund¹¹ and Jochen Casper^11*

¹Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
²Department of Bone Marrow Transplantation, University Hospital Essen, Germany
³Department of Medicine - Hematology, Oncology, University of Freiburg, Germany
⁴University Department of Hematology and BMT, Silesian Medical University, Katowice, Poland
⁵Medical Clinic III - Hematology and Oncology, Charité University Medicine Berlin, Germany
⁶Department of Hematology/Oncology, University of Muenster, Germany
⁷Centre for Allogeneic Stem Cell Transplantation & Department of Hematology, Karolinska University Hospital & Karolinska Institute, Stockholm, Sweden
⁸Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹Division of Stem Cell Transplantation & Immunotherapy, 2nd Medical Department; University of Kiel, Germany
¹⁰Department of Hematology/Oncology, University of Wuerzburg, Germany
¹¹Division of Hematology and Oncology, University of Rostock, Germany

G. Milone, M. Poidomani^*, S. Coppoletta^*, E. Mauro^*, E. Marturano^*, F. Crispi^*, A. Spadaro^*, A. Di Marco^* and S. Leotta^*

Hematology, Bone Marrow Transplantation Unit, Catania, Italy

Philipp Hemmati¹, Theis Terwey^1*, Gero Massenkeil, MD^2*, Philipp D. le Coutre, MD³, Stefan Neuburger^1*, Lam G Vuong^1*, Bernd Dörken^1* and Renate Arnold, MD, PhD^1*

¹Department of Hematology and Oncology, Charité - University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
²Department of Internal Medicine, Hematology and Oncology, Ruhr-University Bochum
³Department of Hematology and Oncology, Charité - Humboldt-Universitat, Campus Virchow, Berlin, Germany

Pere Barba^1*, Jose Luis Piñana^2*, Alex Amoros^3*, David Valcárcel^2*, Rodrigo Martino^2*, Anna Sureda^2*, Javier Briones^2*, Julio Delgado^2*, Miquel Granell^2*, Salut Brunet^2*, M.ª Rosa Suñol^3* and J. Sierra, MD¹

¹Clinical Hematology, Hospital De Sant Pau, Barcelona, Spain
²Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
³Institut Universitari Fundació Avedis Donabedian, Barcelona, Spain

Philipp Hemmati¹, Gero Massenkeil, MD^2*, Theis Terwey^1*, Stefan Neuburger^1*, Philipp D. le Coutre, MD³, Lam G Vuong^1*, Bernd Dörken^1* and Renate Arnold, MD, PhD^1*

¹Department of Hematology and Oncology, Charité - University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
²Department of Internal Medicine, Hematology and Oncology, Ruhr-University Bochum
³Department of Hematology and Oncology, Charité - Humboldt-Universitat, Campus Virchow, Berlin, Germany

Christy Stotler, DO¹, Paul Elson, ScD^2*, Brian Bolwell, MD¹, Matt Kalaycio, MD¹, Brad Pohlman, MD^1*, Ronald Sobecks, MD¹, Robert Dean, MD¹, Steven Andresen, DO^1*, Edward Copelan, MD^1*, Josephine Chan^1* and John Sweetenham, MD^1*

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Axel Nogai, Dr.^1*, Eckhard Thiel, Prof., Dr., Dr.¹, Thomas Burmeister, Dr.^1*, Susanne Ganepola^1*, Rita Lippoldt^1*, Igor W. Blau, PD, Dr.^1*, Olga O. Blau, MD, PhD¹, Carola Tietze-Bürger^1*, Lutz Uharek, Prof., Dr.^2* and Stefan Schwartz, Dr.^1*

¹Medizinische Klinik III (Haematologie, Onkologie und Transfusionsmedizin), Charite Campus Benjamin Franklin (Charite Centrum 14), Berlin, Germany
²Medical Clinic III - Hematology and Oncology, Charité University Medicine Berlin, Germany

Fleur M Aung, MD^1*, Aida Narvios, MD² and Benjamin Lichtiger^2*

¹Laboratory Medicine, UT MD ANDERSON CANCER CENTER, Houston, TX
²Laboratory Medicine, UT MD Anderson Cancer Center, Houston, TX

HengXiang Wang^*, Hong-Min Yan^*, Lian-Ning Duan^*, Ling Zhu^*, Mei Xue^* and Jing Liu^*

Department of Hematology, General Hospital of PLA, Beijing, China

Carol Jones^1*, Renee Letzinger^2*, James L. Zehnder, MD³ and David Miklos, MD, PhD⁴

¹Pathology, Stanford University, School of Medicine, Palo Alto, CA
²Medicine, Division of Bone Marrow Transplantation, Stanford University, Stanford, CA
³Hematology, Stanford Univ. Medical Center, Stanford, CA
⁴Stanford University School of Medicine, Stanford, CA

Kai yan Liu^1*, Xiao Jun Huang¹, Yu hong Chen^1*, Huan Chen^1*, Lan ping Xu^1*, Xiao hui Zhao^1*, Ting Zhao^1*, Yu Wang^1*, Jin Wang^1*, Wei Han^1* and Chun hua Zhao^2*

¹Institute of Hematology, Beijing, China
²ICenter of Excellence in Tissue Engineering, nstitute of BasicMedical Sciences, CAMS & PUMC,, Beijing, China

Emilio Paolo Alessandrino^1*, Luca Malcovati^1*, Giorgio La Nasa^2*, Paolo de Fabritiis^3*, Massimo Bernardi^4*, Paolo Di Bartolomeo^5*, Paolo Bernasconi¹, Anna A Colombo^1*, Daniela Caldera^1*, Cristiana Pascutto^1*, Patrizio Mazza^6*, Franco Narni^7*, Rosanna Scime'^8*, Attilio Olivieri⁹, Marco Casini^10* and Andrea Bacigalupo for GITMO^11*

¹Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
²Cagliari University
³Hematology, University Tor Vergata, Rome, Italy
⁴Hematology and Bone Marrow Transplantation Unit, IRCCS H San Raffaele, Milano, Italy
⁵Unità Terapia Intensiva Ematologica per il Trapianto Emopoietico, Ospedale Civile, Pescara, Italy
⁶Ematologia-Taranto, Italy
⁷Division of Hematology, Modena University Hospital, Modena, Italy
⁸Hematology, Ospedale Cervello, Palermo, Italy
⁹Ospedale San Carlo, Potenza, Italy
¹⁰Department of Hematology, Bolzano Central Hospital, Bolzano, Italy
¹¹Ospedale S. Martino, Genova, Italy

Margaret O'Donnell¹, P Parker^1*, A Dagis^1*, ML Slovak^1*, D Snyder^1*, A Stein^1*, R. Spielberger^2*, A Pawlowska^1*, J Rosenthal^1*, J Palmer^1*, N. Kogut^2* and S. J Forman^1*

¹City of Hope, Duarte, CA
²Kaiser Permanente, Duarte, CA

Michael Koldehoff, MD^*, Ahmet H. Elmaagacli^* and Dietrich W. Beelen^*

Dept. of Bone Marrow Transplantation, Univ. of Duisburg-Essen, Essen, Germany

Sophie Marty-Grès^1*, Marielle Moussiere^1*, Odile Avinens^1*, Monique Andary^1*, Annie Ramounau-Pigot^1*, Patrice Ceballos^2*, Jean-Côme Meniane^2*, Geneviève Margueritte^3*, Nathalie Fegueux^2*, Jean-Francois Rossi² and Jean-François Eliaou^1*

¹Laboratory of Immunology, CHU Montpellier, Montpellier, France
²Hematology-Oncology, CHU Montpellier, Montpellier, France
³Pediatric Onco-Hematology, CHU Montpellier, Montpellier

Stacy E Melanson, MD, PhD^1*, Joseph H. Antin, MD², Michael H. Court, PhD^3*, Vincent Ho^4*, Jerome Ritz, MD⁵, Haesook T. Kim^6*, Frank C Kuo, MD, PhD^1*, Janina A Longtine, MD^1* and Petr Jarolim, MD, PhD⁷

¹Pathology, Brigham and Women's Hospital, Boston, MA
²Brigham & Women's Hospital, Dana-Farber Cancer Inst., Boston, MA
³Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA
⁴Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Harvard Medical School, Brigham and Women's Hosp., Boston, MA

Julie Kanter, MD, Manasa Kanthamneni^*, Shannon Witty^*, Yvonne Barnes^*, Robert Hayashi^* and Shalini Shenoy^*

Pediatric Hematology/Oncology, Washington University, St. Louis, MO